Dose‐Dependent Inhibition of OATP1B by Rifampicin in Healthy Volunteers: Comprehensive Evaluation of Candidate Biomarkers and OATP1B Probe Drugs

Clinical Pharmacology and Therapeutics - United States
doi 10.1002/cpt.1695

Related search